As Halloween creeps closer, the stock market shows no signs of fear – just a whole lot of candy treats.

Historically, Halloween has been a frightfully favourable day for investors. According to Dow Jones Market Data, the S&P 500 and the TSX typically rise by an average of 0.19% on Halloween, while the Dow gains 0.15%, and the Nasdaq sees a ghostly average increase of 0.43%.

But it’s not just the market that’s feeling the festive spirit – consumer spending on Halloween treats is also making headlines. The National Retail Federation’s annual survey, conducted by Prosper Insights & Analytics, reveals that Americans are expected to spend a whopping $2.6 billion on candy this year, averaging more than $25 per person. With 68% planning to celebrate by handing out candy on Halloween, it’s clear that this season is sweeter than ever.

In the above video, we explore a brew of companies riding witches’ brooms into the moonlight and into your portfolios. As the stock market continues to cast its spell, these investments are set to conjure up solid returns. So, as you prepare for a season of spooky celebrations, remember the real magic might just be happening in your portfolio. Happy Halloween; may your investments be as thrilling as a midnight ride.

Be sure to stay up to date on all the latest stock market news at Stockhouse.com.

Join the discussion: Find out what everybody’s saying about public companies on Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

System1 shares jump as MapQuest rides Lake Ontario drama to no. 1 app ranking

System1 stock (NYSE:SST) jumped 25% Thursday as MapQuest surged to the No. 1 navigation app in the U.S. following a spike in downloads.

East Side Games gets lean, trims workforce, re-works portfolio

East Side Games Group (TSX:EAGR) reduced its workforce by approximately 30 employees, or 32% of staff, to improve efficiency and profitability

Restart Life Sciences serves up exponential revenue growth

Restart Life Sciences (CSE:HEAL) more than doubled revenue at stable profit margins in Q2 2026 amid several promising commercial activations.

A rival to Coke’s coca leaf monopoly is coming to the CSE

Power Leaves (CSE:NASA) completes its reverse takeover of Atmofizer Technologies, setting the company up for an imminent listing on the CSE.